208 related articles for article (PubMed ID: 31245174)
41. Comprehensive Assessment of Plasma Circ_0004771 as a Novel Diagnostic and Dynamic Monitoring Biomarker in Gastric Cancer.
Xu Y; Kong S; Qin X; Ju S
Onco Targets Ther; 2020; 13():10063-10074. PubMed ID: 33116589
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic potential of extracellular vesicle-associated microRNA-10b and tumor markers for lung adenocarcinoma.
Yuan G; Xie H; Wei T; Zhu D; Zhang C; Yang Y
Oncol Lett; 2021 Aug; 22(2):614. PubMed ID: 34257722
[TBL] [Abstract][Full Text] [Related]
43. Plasma miR-1, but not Extracellular Vesicle miR-1, Functions as a Potential Biomarker for Colorectal Cancer Diagnosis.
Xu B; Shen X; Yang Z; Zhao T; Liu B; Gao S; Shi Y; Bao C
Clin Lab; 2021 Jan; 67(1):. PubMed ID: 33491425
[TBL] [Abstract][Full Text] [Related]
44. Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer.
Zhuang K; Han K; Tang H; Yin X; Zhang J; Zhang X; Zhang L
Med Sci Monit; 2016 Feb; 22():356-61. PubMed ID: 26835790
[TBL] [Abstract][Full Text] [Related]
45. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.
Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063
[TBL] [Abstract][Full Text] [Related]
46. A Panel of Circulating microRNAs as a Potential Biomarker for the Early Detection of Gastric Cancer.
Saliminejad K; Mahmoodzadeh H; Soleymani Fard S; Yaghmaie M; Khorram Khorshid HR; Mousavi SA; Vaezi M; Ghaffari SH
Avicenna J Med Biotechnol; 2022; 14(4):278-286. PubMed ID: 36504565
[TBL] [Abstract][Full Text] [Related]
47. Clinical role of circulating miR-223 as a novel biomarker in early diagnosis of cancer patients.
Zhou X; Ji G; Chen H; Jin W; Yin C; Zhang G
Int J Clin Exp Med; 2015; 8(9):16890-8. PubMed ID: 26629240
[TBL] [Abstract][Full Text] [Related]
48. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer.
Cai H; Yuan Y; Hao YF; Guo TK; Wei X; Zhang YM
Med Oncol; 2013 Mar; 30(1):452. PubMed ID: 23307259
[TBL] [Abstract][Full Text] [Related]
49. Expression Analysis of mir-21 and mir-221 in Cancerous Tissues from Iranian Patients with Gastric Cancer.
Effatpanah H; Yadegarazari R; Karami M; Majlesi A; Shabab N; Saidijam M
Iran Biomed J; 2015; 19(4):188-93. PubMed ID: 26209976
[TBL] [Abstract][Full Text] [Related]
50. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
Wang XF; Wu YH; Wang MS; Wang YS
Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
[TBL] [Abstract][Full Text] [Related]
51. microRNA-365 inhibits YAP through TLR4-mediated IRF3 phosphorylation and thereby alleviates gastric precancerous lesions.
Zhang T; Zhang K; Ji K; Zhang C; Jiang Y; Zhang Q; Tian Z; Wang X; Zhang M; Li X
Cancer Cell Int; 2020 Nov; 20(1):549. PubMed ID: 33292210
[TBL] [Abstract][Full Text] [Related]
52. The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review.
Li H; Wu Q; Li T; Liu C; Xue L; Ding J; Shi Y; Fan D
Oncotarget; 2017 Jul; 8(28):45060-45071. PubMed ID: 28178677
[TBL] [Abstract][Full Text] [Related]
53. MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer.
Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
J Surg Oncol; 2013 Aug; 108(2):89-92. PubMed ID: 23733518
[TBL] [Abstract][Full Text] [Related]
54. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic effects and safety of apatinib mesylate on patients with gastric carcinoma peritoneal metastasis in SOX scheme.
Wang HF; Wang HH; Ye XJ; Wang WJ; Teng LS
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6627-6638. PubMed ID: 37522674
[TBL] [Abstract][Full Text] [Related]
56. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
Jiang L; Li X; Cheng Q; Zhang BH
Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
[TBL] [Abstract][Full Text] [Related]
57. The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer.
Li F; Guo Y; Liu J; Zhang R
PLoS One; 2017; 12(5):e0178427. PubMed ID: 28562634
[TBL] [Abstract][Full Text] [Related]
58. Plasma lipids signify the progression of precancerous gastric lesions to gastric cancer: a prospective targeted lipidomics study.
Liu ZC; Wu WH; Huang S; Li ZW; Li X; Shui GH; Lam SM; Li BW; Li ZX; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
Theranostics; 2022; 12(10):4671-4683. PubMed ID: 35832080
[No Abstract] [Full Text] [Related]
59. Cell-free miR-17-5p as a diagnostic biomarker for gastric cancer inhibits dendritic cell maturation.
Cui ZJ; Xie XL; Qi W; Yang YC; Bai Y; Han J; Ding Q; Jiang HQ
Onco Targets Ther; 2019; 12():2661-2675. PubMed ID: 31040704
[TBL] [Abstract][Full Text] [Related]
60. Circulating microRNA-196a is an early gastric cancer biomarker.
Chen TH; Lee C; Chiu CT; Chu YY; Cheng HT; Hsu JT; Tsou YK; Wu RC; Chen TC; Chang NC; Yeh TS; Lin KH
Oncotarget; 2018 Feb; 9(12):10317-10323. PubMed ID: 29535809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
